Annual Drug Patent Expirations for LEVOLET Levolet is a drug marketed by Genus Lifesciences and is included in one NDA. The generic ingredient in LEVOLET is levothyroxine sodium. Additional details…
The post New patent for Genus Lifesciences drug LEVOL…
Annual Drug Patent Expirations for KISQALI Kisqali is a drug marketed by Novartis and is included in two NDAs. It is available from one supplier. There are eight patents protecting…
The post New patent for Novartis drug KISQALI appeared first on DrugPa…
ALPHAGAN P (brimonidine tartrate) Allergan Patent: 9,295,641 Expiration: Jan 10, 2022 See More … For more information on how DrugPatentWatch can help with your pharmaceutical business intelligence needs, contact [email protected]…
The post Drug…
Drug Patent Expirations for the Week of January 9, 2022 Read Post »
Annual Drug Patent Expirations for LASTACAFT Lastacaft is a drug marketed by Allergan and is included in one NDA. It is available from one supplier. There are two patents protecting…
The post New patent for Allergan drug LASTACAFT appeared first on Dru…
This chart shows the drug companies with the most supplementary protection certificates (SPCs). SPCs are used in European Union and select others to encourage pharmaceutical innovation by compensating for the…
The post Which pharmaceutical companies ha…
This chart shows the pharmaceutical companies with the most patents in Malaysia. Patents must be filed in each country (or, in some cases regional patent office) where patent protection is…
The post Which pharmaceutical companies have the most drug pat…
Which pharmaceutical companies have the most drug patents in Malaysia? Read Post »
Annual Drug Patent Expirations for ALPHAGAN+P Alphagan P is a drug marketed by Allergan and is included in two NDAs. It is available from one supplier. There are eight patents…
The post New patent expiration for Allergan drug ALPHAGAN P appeared first …
New patent expiration for Allergan drug ALPHAGAN P Read Post »
This chart shows the drugs with the most supplementary protection certificates (SPCs). SPCs are used in European Union and select others to encourage pharmaceutical innovation by compensating for the long…
The post Which drugs have the most supplementa…
Which drugs have the most supplementary protection certificates? Read Post »
Annual Drug Patent Expirations for GIVLAARI Givlaari is a drug marketed by Alnylam Pharms Inc and is included in one NDA. There are twelve patents protecting this drug. This drug…
The post New patent expiration for Alnylam Pharms drug GIVLAARI appeared…
New patent expiration for Alnylam Pharms drug GIVLAARI Read Post »
Annual Drug Patent Expirations for ICLUSIG Iclusig is a drug marketed by Takeda Pharms Usa and is included in one NDA. It is available from one supplier. There are three…
The post New patent for Takeda Pharms drug ICLUSIG appeared first on DrugPatentWa…
Get new actionable insights and updates from BiotechBlog
